Cbd Pain Relief Roll on

Description

INVIG is a roll-on formulation containing broad-spectrum hemp CBD, specifically designed for pain relief. Each 3 fl oz (88 ml) container delivers 150 mg of CBD, ensuring a fast-acting relief without the presence of THC. The product is formulated to provide targeted application, enhancing its efficacy in alleviating discomfort.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with sore muscles and joints, backache, and arthritis.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to administer the product strictly as directed. Prior to each application, the container should be shaken well to ensure proper mixing of the formulation. The product is intended for topical use; it should be applied using a roll-on method to the affected area. The maximum frequency of application is four times daily.

It is important to note that this product is not recommended for use in children under 12 years of age.

Contraindications

The product is contraindicated in the following situations:

Use with a heating pad is prohibited due to the potential for increased risk of burns or skin irritation. Bandaging the area after application is also contraindicated, as it may lead to excessive heat retention and skin damage.

Healthcare professionals should advise patients to wash their hands with cold water immediately after use and to avoid contact with eyes or mucous membranes to prevent irritation.

Patients should discontinue use and consult a physician if redness or irritation occurs, if the condition worsens, or if pain persists for more than 7 days or resolves and then recurs.

Prior to use, individuals with sensitive skin, those who are pregnant or breastfeeding, or those taking any medications should seek medical advice.

In the event of accidental ingestion, immediate medical assistance should be sought or the Poison Control Center contacted.

Warnings and Precautions

This product is intended for external use only. It is important to note that the formulation is flammable; therefore, it should be kept away from open flames and heat sources. To ensure safety, the product must be stored out of reach of children.

Prior to use, individuals should consult a healthcare professional if they have sensitive skin, are pregnant, breastfeeding, or are currently taking any medications. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted.

The product should not be used in conjunction with heating pads, nor should it be bandaged after application. Users are advised to wash their hands with cold water immediately after use and to avoid contact with eyes and mucous membranes to prevent irritation.

If any redness or irritation develops, or if the condition worsens, it is imperative to discontinue use and consult a healthcare provider. Additionally, if pain persists for more than 7 days or if symptoms resolve and then reoccur, medical advice should be sought.

Side Effects

Patients should be aware that the product is for external use only and is flammable. It is important for individuals with sensitive skin, those who are pregnant or breastfeeding, or those taking any medications to consult a doctor prior to use.

In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately. The product should not be used in conjunction with a heating pad, nor should it be bandaged after application. Patients are advised to wash their hands with cold water immediately after use and to avoid contact with eyes or mucous membranes.

Patients should discontinue use and consult a doctor if they experience redness or irritation, if their condition worsens, or if pain persists for more than 7 days or resolves only to reoccur.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Cbd Pain Relief Roll on (menthol, unspecified form). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not use this medication. Safety and efficacy have not been established in this population, and therefore, it is contraindicated for children in this age group. Healthcare professionals should consider alternative treatments for pediatric patients who fall within this age range.

Geriatric Use

Elderly patients may require careful consideration when prescribing this medication. It is important to note that the use of this medication is contraindicated in children under 12 years of age.

Healthcare providers should exercise caution when administering this medication to geriatric patients, as age-related physiological changes may affect drug metabolism and response. Monitoring for efficacy and adverse effects is recommended, particularly in this population.

Dosage adjustments may be necessary based on individual patient factors, including renal and hepatic function, which can be more variable in elderly patients. Regular assessment and close monitoring are advised to ensure optimal therapeutic outcomes while minimizing potential risks.

Pregnancy

Pregnant patients should contact their healthcare provider before using this medication. It is important for women who are pregnant, breastfeeding, or taking any other medications to discuss their individual circumstances with a doctor to ensure safety and appropriate management. The potential risks and benefits should be carefully considered in these populations.

Lactation

Lactating mothers are advised to contact a healthcare professional before using this medication if they are breastfeeding or taking any other medications. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication during lactation.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to patients with renal impairment.

Hepatic Impairment

There is no available information regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the overall clinical context when prescribing this medication to patients with liver problems, as the absence of specific guidance necessitates careful evaluation of potential risks and benefits.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the product is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion or misuse. Patients should be instructed not to use the product in conjunction with a heating pad, as this may lead to adverse effects. Additionally, it is important to inform patients that they should not bandage the area after application.

Patients must be counseled to wash their hands with cold water immediately after using the product and to avoid touching their eyes or mucous membranes to prevent irritation. They should be made aware that if they experience redness or irritation, if their condition worsens, or if pain persists for more than 7 days or resolves only to reoccur, they should stop using the product and consult a doctor.

Furthermore, healthcare providers should emphasize the importance of contacting a doctor before using the product if the patient has sensitive skin, is pregnant, breastfeeding, or is taking any medications. In the event of accidental ingestion, patients should seek medical help or contact a Poison Control Center immediately.

Storage and Handling

The product is supplied in a container that must be stored in a cool, dry place. It is essential to ensure that the cap is tightly closed to maintain the integrity of the product. Proper storage conditions are crucial for preserving the quality and efficacy of the product.

Additional Clinical Information

The product is administered topically, with a recommended application of a roll-on to the affected area no more than four times daily. Clinicians should advise patients that the product is for external use only and is flammable. It is essential to keep the product out of reach of children and to contact a doctor prior to use if the patient has sensitive skin, is pregnant, breastfeeding, or taking other medications.

Patients should be informed to seek medical assistance or contact a Poison Control Center immediately if the product is swallowed. Additionally, it should not be used in conjunction with a heating pad or bandaged, and hands should be washed with cold water immediately after application, avoiding contact with eyes or mucous membranes. Patients are advised to discontinue use and consult a doctor if redness or irritation occurs, if the condition worsens, or if pain persists for more than seven days or resolves and then recurs.

Drug Information (PDF)

This file contains official product information for Cbd Pain Relief Roll on, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)